# Short-term Antibiotic Therapy for Pyelonephritis in Childhood

> **NCT00724256** · PHASE3 · TERMINATED · sponsor: **IRCCS Burlo Garofolo** · enrollment: 36 (actual)

## Conditions studied

- Pyelonephritis

## Interventions

- **DRUG:** ceftibuten
- **DRUG:** ceftibuten

## Key facts

- **NCT ID:** NCT00724256
- **Lead sponsor:** IRCCS Burlo Garofolo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2009-07
- **Final completion:** 2010-07
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** other upcoming studies; patients refusal of invasive follow up (DMSA)
- **Last updated:** 2012-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00724256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00724256, "Short-term Antibiotic Therapy for Pyelonephritis in Childhood". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00724256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*